Site Map · Contact Us
Philanthropy in Global Health: Speakers

Prof Helmut K. Anheier

Helmut K. Anheier (Ph.D. Yale University, 1986) is Professor of Sociology, Heidelberg University, and the Academic Director of the Center for Social Investment.  He is Professor of Public Policy and Social Welfare at UCLA, and Centennial Professor at the London School of Economics.  He founded and directed the Centre for Civil Society at LSE, and the Center for Civil Society at UCLA. Prior to this he was a Senior Research Associate and Project Co-director at the Johns Hopkins University Institute for Policy Studies, and Associate Professor of Sociology at Rutgers University. Before embarking on an academic career, Dr. Anheier served as Social Affairs Officer at the United Nations. Dr. Anheier’s work has focused on civil society, the nonprofit sector, philanthropy, organizational studies, policy analysis and comparative methodology.  He is author of over 250 publications, including over thirty authored and edited books. He has won several national and international awards, including the 2006 PNP Best Book Award of the American Academy of Management. He is currently researching the role of philanthropy internationally, and interested in methodological questions at the intersection of globalization, civil society, and culture.  Dr. Anheier serves on the board of several scholarly and philanthropic organizations.
> Powerpoint presentation

Dr Hans-Peter Bauer

Peter Bauer studied Economics and Business Administration at St. Gallen University in Switzerland and the London School of Economics. He spent his entire professional career with Swiss Bank Cooperation and, since the merger, with UBS. His major tasks included that of a Chief Operations Officer for the German subsidiary of SBC, the build-up and the management of a Global Compliance Organisation, Head of Divisional Governance (Legal, Compliance, Communications) for the Global Private Bank, the Chief Risk Officer for the Retail Bank in Switzerland and the Global Private Bank and, finally, he acted as Global Head of Regulatory Relations and Strategy for the UBS Group.

In April of 2004, after 26 years of a banking career, Peter decided to retire to have more time for strategic aspects of compliance at large and, in particular, money laundering, the fight against terrorism, corruption and financial crime as well as their impact on the reputation risk for the firm. Peter is also one of the initiators and a founding member of the Wolfsberg Group which has actively contributed to international standards against money laundering (incl. corruption) and the financing of terrorism.

Today he acts as Senior Advisor to the Wolfsberg Group and the Basel Institute of Governance as well as international organizations and banks.

Kazem Behbehani

He was a Post Doctoral Fellow at the London School of Hygiene and Tropical Medicine and the Mathilda and Terence Kennedy Institute of Rheumatology in London, the Vice Dean of the Faculty of Medicine and the Vice President of Kuwait University. He was Deputy Director General of Kuwait Institute for Scientific Research and a member of the Management Board of the IBM Scientific Centre, Kuwait. Director of WHO AIDS Collaborative Centre (Kuwait), and member of WHO Global Programme of AIDS (GPA) Management Committee (Geneva).

He was Professor of Immunology and Medical Parasitology at Kuwait Medical Faculty and a Visiting Scholar/Professor at the Harvard Medical School (Boston).

At WHO (1990-2005), he worked in the vaccine research of the Global programme of AIDS, the Programme Manager of Tropical Disease Research (TDR), the Director of both the Division of the Control of Tropical Diseases and, the Eastern Mediterranean Liaison Office in Geneva. He served as a member of the WHO Board of Appeal, Secretary of number of Intergovernmental meetings (e.g. Tobacco Convention), as well as several of the committees/subcommittees of the Executive Board and the World Health Assembly. WHO Assistant Director-General, External Relations and Governing Bodies (2003-5), and the WHO Envoy (2005-06).

He was the Chairman of the International Atomic Energy Agency (IAWA)'s External Panel for the Evaluation of Human Health Programme (2005).

He continues to be a Fellow of the Royal College of Pathologists (UK), a member of several scientific and technical bodies.  He is a trustee of number of international charitable bodies and foundations including, The Children High Level Group (UK) and AMAR International Foundation (UK).  He is a founding member of The Geneva Foundation for Diseases of Tropics and co-founder and president of Leader Health srl.

He is a member of the Ethics Review committee (2005 - ), International Agency for Research on Cancer (IARC). Co-Chairman of Scientific Advisory Board of Harvard / Cyprus initiative on Environment and Public Health.

He is the recipient of several awards and scientific recognitions, including the Kuwait Foundation for the Advancement of Science's (KFAS) Best Researcher in Medicine. He served as a member of the Editorial Board of a number of scientific journals. He has more than 100 scientific publications and one book on science and technology to his credit.

He continues to be interested in environment and health issues, health management, and the application of information technology to healthcare delivery (eHealth) and development of interactive educational materials (eLearning) for the public, professionals for medical education, management issues as well as art.

Dr Rob Donnelly

Dr Donnelly grew up in Perth Scotland and studied Medicine at Edinburgh University.  He joined the Royal Army Medical Corps and spent six years in a variety of roles, with the Infantry in Northern Ireland and London, Army hospitals in Hong Kong and London and finally a mobile armored field unit in the West of England. He completed training as a General Practitioner before leaving the Army to train in Occupational Medicine at British Steel in South Wales.  After six years in a variety of roles in the Steel Industry he moved to Shell in Aberdeen working in the offshore Exploration and Production sector.  A move to Houston Texas followed where for four years he led Shell Health Services in the Americas. This involved multiple business units in 34 countries. In March 2007 he moved the Hague Netherlands to assume his current position as Vice President Health for Royal Dutch Shell plc.  He is accountable for 650 staff in 130 countries where Shell has operational interests. His professional interests include fitness to work and environmental health. In his spare time he enjoys family, sport and photography.
> Powerpoint presentation

David Hayward Evans

David Hayward Evans, Corporate Partnerships Manager at the Global Fund to Fight AIDS, Tuberculosis and Malaria, is a dual Swiss-British national. The Corporate Partnership Programme, which he leads, has been launched in early 2008. David he has more than ten years experience creating public-partnerships bridging business, governments and international organizations.  In recent years, he performed this role for British government projects launched by Prime Minister Tony Blair, including the UK-India Education and Research Initiative, and the “Think UK” public diplomacy campaign in China. Previously he was responsible for international development at the Paley Center for Media in New York.  A fluent Chinese speaker, he is a graduate of Oxford University, Columbia University and INSEAD.
> Abstract and powerpoint presentation

Gretta Fenner

Gretta Fenner is a political scientist by training and holds a masters degree from the Otto-Suhr-Institute for political science (Otto-Suhr-Institut für Politikwissenschaften) of the Freie Universität Berlin, Germany, and a degree in political sciences from the Paris Institute for Political Science (Institut d'Etudes Politiques - IEP, or "Sciences Po").

Before joining the Basel Institute on Governance as its Director in November 2005, she has worked at the Anti-Corruption Division of the Organisation for Economic Co-operation and Development (OECD), where she was responsible for cooperation with non-OECD member countries from Asia and the Pacific. In cooperation with the Asian Development Bank, she in particular developed and accompanied the implementation of the ADB/OECD Anti-Corruption Initiative for Asia-Pacific. In this framework, she assisted countries from the region in designing and implementing legal and institutional anti-corruption and governance reform. She further oversaw capacity building programmes in such diverse areas as prosecution of corruption, prevention of corruption in public procurement, and implementation of the UN Convention against Corruption, and directed and contributed to various publications on anti-corruption reform and institutions in the Asia-Pacific region. Also at the OECD Anti-Corruption Division, she has also been involved in similar projects in Central and Eastern Europe, South-East Europe, and the Middle East-North Africa region.

Gretta regularly speaks at international gatherings and conferences on governance, corruption and asset recovery issues. She is a member of the UNODC expert group on the UNCAC review mechanisms, of the World Economic Forum Partnering Against Corruption Task Force, and participates as expert in the Wolfsberg Group.

Silvio Gabriel

Silvio Gabriel is Executive Vice President and General Manager of Malaria Initiatives at Novartis. In this role, Mr Gabriel has direct responsibility for managing the Novartis initiative on malaria. Mr Gabriel’s responsibilities encompass all aspects of the antimalarial drug Coartem, from production and supply to marketing, life cycle management and alliance management with external stakeholders such as WHO and Global Fund to ensure supply of this lifesaving drug to millions of patients. Silvio C. Gabriel assumed his current role in 2005 from his previous position as Head Novartis Pharma Region Europe which included Africa and the Middle East. In that position, which Mr Gabriel assumed in 2000, he supervised the operations of affiliates in 28 countries, with over 10,000 employees. For 2004, his teams in Region Europe achieved sales of USD 6 billion making Novartis No. 4 within the ranking of pharmaceutical companies in Europe. He joined the company in 1983 and started his career with functions in Controlling, Market Research and Strategic Planning at the headquarters in Switzerland and the Pharma Division in Brazil. From 1988 to 1991, he held the position of CEO of the Pharma Division in Portugal. After two years as assistant to the worldwide head of the Pharma Sector, he functioned as CEO of the Pharma Organisation in Germany from 1994 to 2000. During his eleven years as Country CEO, he continually improved market share and profitability of Novartis Pharma in Portugal and Germany, being selected for the Novartis Excellence Award in 1997 and 1999. From 2000 to April 2004, he served as Chairman of the Board of Directors of the country organisation in Germany. After completing his studies in economics with honors at the University of Zurich in 1979, he was active in the areas of Finance, Controlling and Strategic Planning at Rieter AG, a textile machinery firm in Switzerland and the US.
> Powerpoint presentation

Dr Chris Hentschel

Dr Chris Hentschel is President and Chief Executive Officer of the Medicines for Malaria Venture (MMV) in Geneva, Switzerland. MMV is a not-for-profit Foundation that aims to facilitate the discovery, development and delivery of affordable new drugs for the treatment of malaria. He graduated in biochemistry from King’s College, London, UK, and obtained a doctorate from the same institution. His early career focused on basic biomedical research, at the Imperial Cancer Research Fund, London, as a lecturer at the Swiss Federal Institute of Technology (ETH), Zurich, and finally as a Fogarty Fellow at the National Institutes of Health, Bethesda, MD, USA. From 1978–1997, Dr Hentschel served as Chief Executive Officer and Scientific Director of the UK Medical Research Council’s Collaborative Centre. He was Head of the Department of Molecular Genetics at Celltech from 1983–1987. In 1999 he became a senior research fellow of the Emerging Technology Program of the Wharton Business School. Dr Hentschel is also a non-executive Director to two biotechnology companies, an advisor to a European venture capital fund and Member of the Supervisory Board of the Global Medical Forum, Zurich and of the High-level Advisory Panel for Global Health Innovations project at the Saïd Business School, Oxford. Dr Hentschel is currently an alternate Member of the Executive Committee of the Roll Back Malaria (RBM) Partnership representing the product development constituency.
> Abstract or powerpoint presentation

Andreas Holzer

Andreas Holzer, 1968, is a sustainability analyst for Bank Sarasin since June 2004. He covers the healthcare sector, chemical industry, and the paper/forestry sector. He also assists in the development of sustainability research procedures and represents the topic in several working groups and institutions. Andreas holds a degree in geography from the University Basel with the minor subjects chemistry and economics. In 1997 he started as a trainee for the environmental management department of UBS in Zurich. From 1998 until May 2004 he was an environmental and social analyst in the research department of Zurich Cantonal Bank (ZKB). There he also served as an internal auditor for the implementation of the ISO 14001 certified environmental management system.
> Abstract and powerpoint presentation

Radha Dawn Ivory

Radha Ivory is a lawyer from Australia. After graduating with dual degrees in International Relations, German and Law from the University of Queensland, she joined the top-tier Australia commercial law firm Freehills.  In August 2006, she relocated to Geneva, Switzerland, where she advised on preventing and responding to cases of abuse and exploitation by humanitarian workers at the International Council of Voluntary Agencies and the Humanitarian Accountability Partnership. In February 2008, she moved to Basel to take up a PhD position at the International Centre on Asset Recovery. Her research is concerned with individual rights in asset recovery cases under international law.
> Powerpoint presentation

Dr Malebona Matsoso

Precious Matsoso is the World Health Organisation Director for Public Health Innovation and Intellectual Property at the Office of the WHO Director General, after having worked as the Director of the Department of Technical Cooperation for Essential Drugs and Traditional Medicines at the same organisation. Prior to that, she was the Registrar of Medicines of the National Drug Regulatory Authority in South Africa, the Medicines Control Council. She has been a senior official in the South African Government for eight years and also served as Secretariat of the Southern African Development Community (SADC) harmonization initiative and has coordinated related activities for the region. She received her Pharmacy degree from the University of the Western Cape and Post Graduate Diploma in Health Management with distinction, from the University of Cape Town. She has been in the forefront of drug policy development in South Africa and its implementation. She has worked in both the public and private sector as a pharmacist and in management positions. She has served in various bodies including Medicines Control Council, which she headed for 7 years, She has been a member of the National Research Ethics Council, and directed the Essential Drugs. Programme for the South African Health Department. She has been a member of various advisory panels locally and internationally, mainly tasked with improving access to medicines and antiretrovirals in particular. She won a Pharmaceutical Society of South Africa Award and is an Oliver Tambo Fellow. She has been instrumental in the transformation medicine regulation in South Africa to be in line with the EU and has been responsible for the development of forty technical guidelines for the medicines regulation in South Africa. She has been appointed to the task team for the ARV rollout in South Africa for which she established pharmacovigilance programme.
> Powerpoint presentation

Donald G. McNeil Jr.

Donald G. McNeil Jr. has been a science and health reporter for The New York Times since 2002. Previously, he was a foreign correspondent based in Johannesburg and then in Paris.  Before that, he was the On Stage and Off theater columnist. He has also served as deputy editor of the culture desk’s Arts & Leisure section, as an editor on the Week in Review, an editor on the metropolitan desk, an environmental reporter, the Long Island bureau chief and as a night rewrite man. Mr. McNeil joined The Times in 1976 as a copy boy, and was promoted to reporter in 1978.  He left in 1979 and taught journalism at Columbia University while studying history.  He worked as a writer for People magazine and WCBS-TV and as an editor for Adweek and New York Newsday before returning to the Times in 1988. Mr. McNeil has covered many topics, ranging from the Love Canal toxic waste scandal to bungee-jumping off Victoria Falls and the premiere of “Evita” in Zimbabwe. Most of his work as a science reporter has been about plagues and pestilences, including AIDS, malaria, mad cow disease, SARS and avian flu.  In 2001, his stories about patent monopolies making it impossible for Africans to afford AIDS drugs was a finalist for a Gerald Loeb award (with Jeff Gerth and Sheryl Stolberg).  In 2002, his series (with Rachel Swarns) about the effects of AIDS on a small South African town won first place in foreign reporting from the National Association of Black Journalists.   In 2006 his series (with Celia Dugger) about diseases on the brink of eradication won the grand prize in the Robert F. Kennedy Memorial Journalism Awards and an Overseas Press Club award. Born in San Francisco, Calif. on Feb. 1, 1954, he graduated summa cum laude from the University of California at Berkeley in 1975 with a bachelor’s degree in rhetoric.  He was executive editor of the Daily Californian. Mr. McNeil is married and lives in Brooklyn. He has two grown daughters and a young stepson.
> Abstract

Vincent Paul Menken

Vincent Paul Menken is Member of the Board Office and Executive Assistant to the Management Board of the Bertelsmann Stiftung. In his current position Vincent flanks the strategic and daily operations but also oversees the partnering and fellowship programmes of Bertelsmann Stiftung. Originating from the city of Luebeck and with a philanthropic family focus Vincent studied law and business at Julius-Maximilians-University Wuerzburg, Universidad de Valenciá and Humboldt-University Berlin. While being in school he set up his first entrepreneurial business and later on helped launching foundation networks. Before joining Bertelsmann Stiftung Vincent worked for the public Foundation Remembrance, Responsibility and Future and an international law and consultant firm. Vincent holds a diploma in law and is part of the Bertelsmann University leadership programme and MIT Cambridge change leadership class. Vincent is passionate about social enterprises and social investing in education and health.
> Abstract and powerpoint presentation

Dr Pascoal Mocumbi

Dr Pascoal Mocumbi is the High Representative of the European and Developing Countries Clinical Trials Partnership (EDCTP) since March 2004. His mandate is to raise the visibility of the EDCTP and gaining political support, particular within Africa, and to contribute to the EDCTP’s fundraising activities. The Partnership aims to contribute towards reducing the burden of the main poverty-related diseases and transferring empowerment to the developing world. Its goal is to accelerate the development of new or improved clinical interventions against HIV/AIDS, tuberculosis and malaria, and build leadership in health research in developing countries, so that they will be able to diagnose and respond to their own needs. Dr Mocumbi is also WHO Good Will Ambassador for Maternal, Newborn and Child Health for the African Region. He also has active role in global health initiatives serving on the Coordinating Committee of the Global HIV Vaccine Enterprise, contributes to the establishment of global coordinating mechanisms for the development of a preventive vaccine against HIV. He serves as Commissioner in the WHO Commission on Social Determinants of Health (CSDH), and on the boards of the Alliance of Health policy and Systems Research (AHPSR), the International Advisory Board (IAB) of Clinical Trials Registry Platform (ICTRP), the International Women Health Coalition (IWHC), and the Medicines for Malaria Venture (MMV) and African Medical Research Foundation (AMREF). In 2005 he was elected to membership of the Institute of Medicine (IOM). Dr Mocumbi was Prime Minister of the Republic of Mozambique from 1994 to 2004. Prior to that, he headed the Ministry of Foreign Affairs during eight years and the Ministry of Health for 6 years. He received his medical degree from the University of Lausanne, did his internship in Switzerland, and practiced medicine as obstetrician & gynaecologist in hospitals throughout Mozambique. As Prime Minister he led the establishment of Mozambique the National AIDS Council to coordinate the implementation of the national HIV response. Dr Mocumbi served (1989-1998) in the World Health Organization’s Task Force on Health and Development. Dr. Mocumbi is committed to the importance of public health as an essential arm for sustainable development. Dr Mocumbi has expertise in health systems and women’s health issues. As Mozambique Heath Minister established the MCH nurses career and initiated the training of non-physicians health professionals for delivering lifesaving emergency obstetric care necessary to reduce maternal mortality. As Prime Minister, he contributed to the substantial progress in fighting poverty and improving human development, and to the transformation of a war-torn Mozambique into one of the well-governed and fastest growing economies of Africa.
> Abstract and powerpoint presentation

Enrico Mollica

Enrico Mollica is Director of The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) in Geneva, a coalition of over 200 international companies committed to the fight against the three diseases.  In this capacity, he leads GBC’s role as focal point of the private sector at the Board of the Global Fund to Fight AIDS, TB and Malaria (GFATM). This includes increasing the level of engagement of private sector companies and business organizations in the activities of the Global Fund through a number of channels such as the provision of financial resources and pro-bono services, as well as co-investment opportunities and partnerships at country level. Before joining GBC in early 2008, he worked for the European Commission as Senior Policy Advisor, Human and Social Development Unit in the Directorate General for Development, and was responsible for the implementation of the European Programme for Action to confront HIV/AIDS, TB and Malaria through the European Union external action.  Enrico has extensive experience with the Global Fund to Fight AIDS, Tuberculosis and Malaria: he has been serving as Alternate Board Member for the European Commission Delegation, as a Member of the Policy and Strategy Committee, and as a Member of the Steering Committee of the Partnership Forum of the GFATM.  His professional experience spans a variety of policy leadership positions at UNDP, the Italian Development Cooperation and the European Commission. A native of Italy, Enrico’s postings brought him to Rome, Djibouti, Tunis, New York and Brussels, and now Geneva. He is a graduate of Columbia University where he earned a Masters in International Public Affairs (MIPA).
> Abstract and powerpoint presentation

Prof Anne Peters

Anne Peters is Professor of Public International Law at the University of Basel, a position she has held since 2001. Prior to taking up this post she was Assistant Professor at the Walther-Schücking-Institute of Public International Law at the Christian Albrechts University Kiel. Originally from Berlin, Anne Peters studied Modern Greek and Spanish as well as law at the universities of Würzburg, Lausanne, and Freiburg in Breisgau. She was awarded the prize from the Scientific Society at Freibrug im Breisgau for her dissertation, and scholarships from the DAAD of the Harvard Law School and the German Research Community for her studies in the USA. Anne Peters has also held teaching and research posts at the Albert Ludwigs University of Freiburg and the Max-Planck-Institute of foreign and international criminal law in Freiburg.

Guy Pfeffermann

CEO and Chairman of the Board of the Management Education & Research Consortium, Mr. Guy Pfeffermann was born in Montauban, France.  He received his Licence en Droit et Sciences Economiques in Paris in 1962 and was awarded first prize, Concours General, a French national inter-university essay competition. Mr. Pfeffermann was a Besse scholar at St.Antony's College, Oxford from 1962-65 and received a B.Litt. (Oxon.) in 1967.  Mr. Pfeffermann joined the World Bank’s Young Professionals Program in December 1966.  He served as Chief Economist for the Latin America and Caribbean Region from 1979-87 and Chief of Debt and Macroeconomic Adjustment division from 1987-88.  He was the Director of the Economics Department and Chief Economist for the International Finance Corporation from 1988-2003.  Since 2003, he has served as the Director of the Global Business School Network of International Finance Corporation.  He retired from the World Bank in 2006. From 2000-2003 he was also an Adjunct Professor at Johns Hopkins University, School of Advanced International Studies.  From 2003-2007, he was a member of the Board of Directors of the Global Giving Foundation (www.globalgiving.org).
> Paper and abstract

Prof Mark Pieth

Mark Pieth is Professor of Criminal Law and Criminology at the University of Basel, Switzerland, since 1993. From 1989 to 1993 he was Head of Section on Economic and Organised Crime in the Swiss Federal Office of Justice (Ministry of Justice and Police). Since 1990 Prof. Pieth has been chairing the OECD Working Group on Bribery in International Business Transactions. He was recently appointed a Member of the Independent Inquiry Committee into the Iraq Oil-for-Food Programme by the UN Secretary General. He has also assumed various presidencies and memberships of national commissions in Switzerland. He has been a consultant to corporations, international organisations and foreign governments on issues related to governance and has participated in the Wolfsberg AML Banking Initiative as a facilitator.

Stephen Robinson

Stephen Robinson has been General Manager of the newly created Novo Nordisk Haemophilia Foundation in Zurich, Switzerland, since 2005. Dr Robinson has worked as a consultant and held positions in international marketing for companies in the biotech/biopharmaceutical industry. He was Director of International Sales and Marketing for Shanghai RAAS Blood Products, Manager of Business Unit Biotechnology/Haemophilia for Wyeth Pharma GmbH, and held several different positions in international marketing for the blood product companies, Octapharma AG and Biotest Pharma GmbH. During his career he has, among other responsibilities, established project management for research projects, led market launches, positioning and sales of products and provided scientific and medical product support. He has worked extensively in developing countries worldwide. Born in 1949, he is a British national with a BSc and a DPhil in Biochemistry from the University of Sussex, Brighton, England. He did the practical work for his doctorate in Schering AG, Berlin.
> Abstract and powerpoint presentation

Dr Klaus Rose

Dr. Klaus Rose was born in Heidelberg, Germany. He qualified in medicine in Berlin after initial studies in Romance languages and psychology leading to an MS in psychology. He completed his postgraduate clinical training in General Medicine in Germany and England before joining the pharmaceutical industry in 1991. Since then, he has held various positions in clinical development of progressively increasing responsibility culminating in the position of Global Head, Pediatrics in Roche Pharmaceuticals since 2005. He is publishing on a regular base on pediatric drug development and is co-editor of the book  “Guide to Paediatric Clinical Research“, of which at present the second edition is in preparation. He is a frequent speaker on national and international conferences on pediatric drug development including academic conferences, the EFGCP (European Forum for Good Clinical Practice, www.efgcp.be), the DIA (Drug Information Association, www.diahome.org),  the ECPM (European Course of Pharmaceutical Medicine, www.ecpm.ch) and others. He also serves as chairman to the EFGCP children’s medicines working party. He is married with two daughters. His private interests include mediterranean style cooking, wine. gardening, Romance languages, and classical guitar.
> Powerpoint presentation

Prof Anton K. Schnyder

Anton K. Schnyder is Professor of Law at the University of Zurich, where he completed his law studies and doctorate degree. Anton Schnyder was awarded the Professor-Walther-Hug-Prize for his doctoral thesis, after which he pursued his studies on a Fulbright scholarship at the University of California in Berkeley (USA), where he was awarded his LL.M. From 1984 to 1987 he undertook research work at the Max-Planck-Institute for Foreign and Private International Law in Hamburg, Germany. Between 1987 and 1993 he was corporate legal adviser to the general secretariat of the Zurich insurance group, as from January 1, 1992 in the capacity of member of the management. He also acts as President of the Federal Appeal commission supervising private insurance. He was Professor of Private Law at the Faculty of Law at Basel University from 1993-2003.

Prof Marcel Tanner

Marcel Tanner has been Professor and Chair of Epidemiology and Medical Parasitology at the University of Basel since 1993 and Honorary Professor of the Faculty of Medicine at the University of Queensland, Brisbane (Australia) since 1996. He is currently the Director of the Swiss Tropical Institute (STI).
Marcel Tanner received his BSc and MSc CHDC (MPH) in biology, chemistry and medical microbiology/immunology from the University of Basel and the London School of Hygiene & Tropical Medicine in 1977 and 1987, respectively, and his PhD in medical parasitology on the in vitro cultivation of trypanosomes from the University of Basel in 1980. He was assistant scientist and held a post-doctoral position studying immune mechanisms against the infective stage larvae of filariae at the STI. Fieldwork started in 1979 in Cameroon and Liberia on onchcerciasis and schistosomiasis. From 1981 to 1984, as Head of the Swiss Tropical Institute Field Laboratory in Ifakara (Tanzania), Marcel Tanner carried out epidemiological research projects on malaria and schistosomiasis and community-based studies on the interactions between infection-nutrition-immunity. There, he also implemented a primary health care programme at district level. These programmes entailed further research, service and training components. From 1988-1995, as Head of the Department of Public Health & Epidemiology at STI, research followed in the field of the control of communicable diseases, mainly malaria and schistosomiasis, based on extended fieldwork in Africa and Asia. Marcel Tanner has been responsible for the health planning emphasising urbanisation, health service utilisation and decentralisation in health planning and resources allocation, on urban environment and health in Africa (Tanzania, Chad, Cameroon, Burkina Faso, Mauritania) and Asia (China, India). Furthermore he assisted/consulted health development projects at district level in rural and urban areas of Africa (Tanzania, Chad, Cameroon) and Asia (India, Thailand) – mainly on behalf of the Swiss Agency for Development and Co-operation. He has taught at universities in Europe, USA, Africa, Australia and Asia in the field of epidemiology and public health and advised on international health issues for governments and international organisations (WHO, World Bank).
He was appointed Member of the Swiss Academy of Medical Sciences in 2003 and Honorary Member of the Swiss Academy of Science in 2005. So far, Marcel Tanner has published over 330 papers in peer-reviewed journals, 19 book chapters, more than 300 short communications and abstracts as well as numerous evaluation reports and studies for governments and international agencies. He is the co-editor of two books on urban health and urbanisation.

PD Dr Kaspar Wyss

Kaspar Wyss is associate professor at the University of Basel and holds a doctoral degree in epidemiology and a Master in Public Health. He is in charge of team of 17 persons at the Swiss Tropical Institute (STI) and directs a number of research and implementation projects including the “Tajik-Swiss Health Reform and Family Medicine Support Project” and various other projects in Eastern Europe and Africa (e.g. Cameroon). He is overseeing the implementation of programs financed by the Global Fund to fight AIDS, TB and Malaria (GFATM) in twelve countries where STI acts as Local Fund Agent. His research interests focus on successful approaches to strengthening health service delivery and the role and importance of managerial, policy and governance processes as well as health workforce development. Within the NCCR North-South on Mitigating Syndromes of Global Change he helds a senior research position thereby focusing research activities on innovative approaches to health service development and human resource related issues.

Teaching for the University of Basel on health systems (MSc and medical students) and for other courses including the Swiss inter university Master of Public Health program.